Arthritis News and Research

Latest Arthritis News and Research

Miniature therapeutic ultrasound device

A prototype of a therapeutic ultrasound device, developed by a Cornell graduate student, fits in the palm of a hand, is battery-powered and packs enough punch to stabilize a gunshot wound or deliver drugs to brain cancer patients.

21 Dec 2008

Patients with skin disease psoriasis need evaluation of coronary artery disease risk

According to new recommendations in the December 10 issue of The American Journal of Cardiology (AJC), published by Elsevier, new research is called for and patients with severe forms of the skin disease psoriasis should receive evaluation and possible treatment to reduce their risk of coronary artery disease (CAD).

18 Dec 2008

Fewer hospitalizations for bleeding in digestive system

Improved treatments for acid reflux disease, ulcers, arthritis and other conditions helped reduce hospital admission rates for internal bleeding in the upper gastrointestinal tract by 14 percent from 1998 to 2006, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

18 Dec 2008

Research highlights recognized disease risks associated with vitamin D deficiency

Once believed to be important only for bone health, vitamin D is now seen as having a critical function in maintaining the immune system throughout life.

17 Dec 2008

Policymakers, the media and the public should use 20 specific health indicators

Policymakers, the media, and the public should focus on 20 specific health indicators as "yardsticks" to measure the overall health and well-being of Americans, says a new report from the Institute of Medicine.

17 Dec 2008

Study to examine how breastfeeding impacts cost of healthcare for very low birth weight babies

The National Institutes of Health (NIH) has awarded nearly $3 million to support Rush University Medical Center's study analyzing how human breast milk impacts the health outcomes and health care cost savings for very low birth weight infants – babies less than 1500 grams.

16 Dec 2008

Study to identify best rehabilitation therapies for patients with traumatic brain injuries

Rush University Medical Center and 10 other healthcare facilities in the U.S. and Canada have been awarded a $4.3 million grant from the National Institutes of Health to identify which rehabilitation therapies, or combination of therapies, can best help victims of traumatic brain injuries.

15 Dec 2008

Lessons from Northwick Park drug-trial disaster

Scientists investigating the 2006 Northwick Park drug-trial disaster that left six healthy volunteers hospitalised say they have developed new pre-clinical tests that could have stopped the trial from ever going ahead.

From The University of Manchester 15 Dec 2008

FDA Class 1 recall for two medical devices

The U.S. Food and Drug Administration (FDA) announced a Class 1 recall today for two unapproved and uncleared devices whose manufacturers claimed could treat various medical conditions. A Class 1 recall means that there is a reasonable probability that the use of a device will cause adverse health consequences or death.

15 Dec 2008

Gene therapy used to treat periodontal disease

Scientists at the University of Michigan have shown that gene therapy can be used to successfully stop the development of periodontal disease, the leading cause of tooth loss in adults.

12 Dec 2008

Mathematical models of adaptive immunity

More than five million people die every year from infectious diseases, despite the availability of numerous antibiotics and vaccines. The discovery of penicillin to treat bacterial infections, along with the development of vaccines for previously incurable virus diseases such as polio and smallpox, achieved great reductions in mortality during the mid-20th century.

11 Dec 2008

12 percent of U.S. children use alternative medicine

Approximately 38 percent of adults in the United States aged 18 years and over and nearly 12 percent of U.S. children aged 17 years and under use some form of complementary and alternative medicine (CAM), according to a new nationwide government survey.

10 Dec 2008

Experimental drug successfully blocks mutation in bone marrow cancers

Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.

10 Dec 2008

Pycnogenol reduces inflammatory marker C-reactive protein in osteoarthritis

Osteoarthritis (OA), a type of arthritis caused by the breakdown and loss of cartilage, affects more than 20 million Americans.

10 Dec 2008

FDA announces permanent injunction against Wilderness Family Naturals

The U.S. Food and Drug Administration has announced that Wilderness Family Naturals LLC of Silver Bay, Minn., and its owners have signed a consent decree that prohibits them from manufacturing and distributing any products with unapproved claims that the products cure, treat, mitigate or prevent diseases.

10 Dec 2008

When is a gun a medical device?

Reports from the United States that authorities there have approved a handgun designed for those crippled by conditions such as arthritis and muscular dystrophy have given rise to confusion and debate.

9 Dec 2008

Rituxan in combination with chemo improves survival in chronic lymphocytic leukemia

Genentech, Inc. and Biogen Idec have announced that two global Phase III studies in chronic lymphocytic leukemia (CLL), CLL8 and REACH, showed Rituxan (rituximab) plus chemotherapy significantly increased the time patients lived without their disease advancing, as defined by the primary endpoint of progression-free survival (PFS), when compared to chemotherapy alone.

8 Dec 2008

Incyte's selective Janus kinase inhibitor demonstrates rapid and durable clinical benefits in Myelofibrosis patients

Incyte Corporation will present updated results from an ongoing Phase II trial of INCB18424, its selective, orally available Janus kinase (JAK) inhibitor, in patients with myelofibrosis (MF) at the 50th American Society of Hematology (ASH) Annual Meeting.

8 Dec 2008

Cartilage transplants used to repair damaged shoulder joints

Rush University Medical Center is the only hospital in Illinois - and one of only a few nationwide - using cartilage transplants to repair damaged shoulder joints.

5 Dec 2008

Better targeted, more cost-effective osteoporosis treatment could soon be a reality worldwide

A new method for determining more accurately at which point someone needs further diagnostic tests, or when immediate treatment is warranted, has been developed by The National Osteoporosis Guideline Group in the UK.

3 Dec 2008

Arthritis News and Research

Latest Arthritis News and Research

Miniature therapeutic ultrasound device

Patients with skin disease psoriasis need evaluation of coronary artery disease risk

Fewer hospitalizations for bleeding in digestive system

Research highlights recognized disease risks associated with vitamin D deficiency

Policymakers, the media and the public should use 20 specific health indicators

Study to examine how breastfeeding impacts cost of healthcare for very low birth weight babies

Study to identify best rehabilitation therapies for patients with traumatic brain injuries

Lessons from Northwick Park drug-trial disaster

FDA Class 1 recall for two medical devices

Gene therapy used to treat periodontal disease

Mathematical models of adaptive immunity

12 percent of U.S. children use alternative medicine

Experimental drug successfully blocks mutation in bone marrow cancers

Pycnogenol reduces inflammatory marker C-reactive protein in osteoarthritis

FDA announces permanent injunction against Wilderness Family Naturals

When is a gun a medical device?

Rituxan in combination with chemo improves survival in chronic lymphocytic leukemia

Incyte's selective Janus kinase inhibitor demonstrates rapid and durable clinical benefits in Myelofibrosis patients

Cartilage transplants used to repair damaged shoulder joints

Better targeted, more cost-effective osteoporosis treatment could soon be a reality worldwide

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Arthritis News and Research

Latest Arthritis News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in